Prague - Delayed Quote CZK

Pilulka Lékárny a.s. (PINK.PR)

Compare
129.50 +3.50 (+2.78%)
As of 3:44 PM GMT+1. Market Open.
Loading Chart for PINK.PR
DELL
  • Previous Close 126.00
  • Open 127.00
  • Bid 126.00 x --
  • Ask 129.50 x --
  • Day's Range 126.00 - 129.50
  • 52 Week Range 112.00 - 333.00
  • Volume 233
  • Avg. Volume 2,233
  • Market Cap (intraday) 350.557M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -64.63
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Pilulka Lékárny a.s. operates a network of pharmacy stores under the Pilulka brand in the Czech Republic, Slovakia, Romania, Hungary, and Austria. The company distributes medicinal products; online sale of pharmacy and related goods for health; and healthy lifestyle and services under the Pilulka brand. It also operates Internet portals, such as Pilulka.cz, Pilulka.sk, Pilulka.ro, Pilulka.hu, and Pilulka.at, as well as an e-shop. The company was founded in 2013 and is headquartered in Prague, the Czech Republic.

www.pilulka.cz

--

Full Time Employees

--

Fiscal Year Ends

Recent News: PINK.PR

View More

Performance Overview: PINK.PR

Trailing total returns as of 11/21/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

PINK.PR
47.36%
MSCI WORLD
17.98%

1-Year Return

PINK.PR
50.19%
MSCI WORLD
24.43%

3-Year Return

PINK.PR
92.07%
MSCI WORLD
16.13%

5-Year Return

PINK.PR
73.83%
MSCI WORLD
56.44%

Compare To: PINK.PR

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PINK.PR

View More

Valuation Measures

Annual
As of 11/20/2024
  • Market Cap

    341.08M

  • Enterprise Value

    407.24M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.16

  • Price/Book (mrq)

    10.38

  • Enterprise Value/Revenue

    0.19

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    -64.63

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: PINK.PR

View More

Company Insights: PINK.PR

Research Reports: PINK.PR

View More

People Also Watch